Bronfman E.L. Rothschild L.P. reduced its holdings in shares of Cooper Companies Inc (NYSE:COO) by 1.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,224 shares of the medical device company’s stock after selling 43 shares during the period. Bronfman E.L. Rothschild L.P.’s holdings in Cooper Companies were worth $1,075,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in the stock. Vanguard Group Inc increased its holdings in shares of Cooper Companies by 0.6% in the third quarter. Vanguard Group Inc now owns 5,041,468 shares of the medical device company’s stock valued at $1,397,243,000 after purchasing an additional 31,280 shares during the period. BlackRock Inc. increased its holdings in shares of Cooper Companies by 7.1% in the fourth quarter. BlackRock Inc. now owns 3,732,729 shares of the medical device company’s stock valued at $949,981,000 after purchasing an additional 246,088 shares during the period. FIL Ltd increased its holdings in shares of Cooper Companies by 16.1% in the third quarter. FIL Ltd now owns 815,901 shares of the medical device company’s stock valued at $226,127,000 after purchasing an additional 113,054 shares during the period. Geode Capital Management LLC increased its holdings in shares of Cooper Companies by 9.7% in the fourth quarter. Geode Capital Management LLC now owns 721,796 shares of the medical device company’s stock valued at $183,414,000 after purchasing an additional 63,889 shares during the period. Finally, Putnam Investments LLC increased its holdings in shares of Cooper Companies by 228.5% in the third quarter. Putnam Investments LLC now owns 622,865 shares of the medical device company’s stock valued at $172,627,000 after purchasing an additional 433,242 shares during the period. 99.95% of the stock is currently owned by institutional investors.

In other news, Director Stanley Md Zinberg sold 740 shares of the company’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $290.03, for a total value of $214,622.20. Following the sale, the director now owns 17,421 shares in the company, valued at $5,052,612.63. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Robert D. Auerbach sold 2,272 shares of the company’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $292.22, for a total value of $663,923.84. Following the completion of the sale, the insider now owns 2,538 shares in the company, valued at approximately $741,654.36. The disclosure for this sale can be found here. Insiders sold 3,811 shares of company stock worth $1,107,763 in the last 90 days. Company insiders own 1.70% of the company’s stock.

Shares of COO opened at $295.23 on Friday. Cooper Companies Inc has a 52 week low of $216.47 and a 52 week high of $299.00. The company has a current ratio of 1.27, a quick ratio of 0.75 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $14.58 billion, a PE ratio of 25.67, a P/E/G ratio of 2.27 and a beta of 0.88.

Cooper Companies (NYSE:COO) last issued its earnings results on Tuesday, March 5th. The medical device company reported $2.88 EPS for the quarter, topping analysts’ consensus estimates of $2.50 by $0.38. Cooper Companies had a return on equity of 17.56% and a net margin of 14.22%. On average, research analysts predict that Cooper Companies Inc will post 12.01 EPS for the current fiscal year.

A number of research analysts have recently weighed in on the company. KeyCorp reissued a “buy” rating on shares of Cooper Companies in a report on Sunday, December 9th. Wells Fargo & Co increased their price objective on Cooper Companies from $305.00 to $325.00 and gave the company an “outperform” rating in a report on Wednesday, March 6th. Stephens increased their price objective on Cooper Companies from $305.00 to $320.00 and gave the company an “overweight” rating in a report on Wednesday, March 6th. BMO Capital Markets increased their price objective on Cooper Companies from $294.00 to $306.00 and gave the company an “outperform” rating in a report on Friday, December 7th. Finally, Goldman Sachs Group lowered Cooper Companies from a “neutral” rating to a “sell” rating and cut their price objective for the company from $233.00 to $221.00 in a report on Friday, January 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $307.90.

TRADEMARK VIOLATION WARNING: “Cooper Companies Inc (COO) Position Cut by Bronfman E.L. Rothschild L.P.” was originally published by Marea Informative and is the property of of Marea Informative. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://www.mareainformativa.com/news/2019/03/17/cooper-companies-inc-coo-position-cut-by-bronfman-e-l-rothschild-l-p.html.

Cooper Companies Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Article: What is the Gross Domestic Product (GDP)?

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.